These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 30034313)
1. Prognostic significance of preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with glioma. Wang J; Xiao W; Chen W; Hu Y EXCLI J; 2018; 17():505-512. PubMed ID: 30034313 [TBL] [Abstract][Full Text] [Related]
2. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer? Deng M; Ma X; Liang X; Zhu C; Wang M Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461 [TBL] [Abstract][Full Text] [Related]
3. The impact of neutrophil-to-lymphocyte, platelet-to-lymphocyte and haemoglobin-to-platelet ratio on localised renal cell carcinoma oncologic outcomes. Albisinni S; Pretot D; Al Hajj Obeid W; Aoun F; Quackels T; Peltier A; Roumeguère T Prog Urol; 2019; 29(8-9):423-431. PubMed ID: 31196826 [TBL] [Abstract][Full Text] [Related]
4. Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma. Que Y; Qiu H; Li Y; Chen Y; Xiao W; Zhou Z; Zhang X BMC Cancer; 2015 Oct; 15():648. PubMed ID: 26432433 [TBL] [Abstract][Full Text] [Related]
5. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer. Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313 [TBL] [Abstract][Full Text] [Related]
6. Preoperative Hematologic Inflammatory Markers as Prognostic Factors in Patients with Glioma. Bao Y; Yang M; Jin C; Hou S; Shi B; Shi J; Lin N World Neurosurg; 2018 Nov; 119():e710-e716. PubMed ID: 30092479 [TBL] [Abstract][Full Text] [Related]
7. Preoperative Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are Associated with the Prognosis of Group 3 and Group 4 Medulloblastoma. Li K; Duan WC; Zhao HB; Wang L; Wang WW; Zhan YB; Sun T; Zhang FJ; Yu B; Bai YH; Wang YM; Ji YC; Zhou JQ; Liu XZ; Zhang ZF; Zhang ZY Sci Rep; 2019 Sep; 9(1):13239. PubMed ID: 31519974 [TBL] [Abstract][Full Text] [Related]
8. Elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis of patients with primary gastrointestinal stromal tumor. Chang WL; Yang WC; Zeng XY; Li CG; Xiong Z; Wang T; Zhang RZ; Tao KX; Zhang P BMC Gastroenterol; 2020 Apr; 20(1):124. PubMed ID: 32321434 [TBL] [Abstract][Full Text] [Related]
9. The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma. Huszno J; Kolosza Z; Mrochem-Kwarciak J; Rutkowski T; Skladowski K Oncology; 2019; 97(1):7-17. PubMed ID: 31048577 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study. Zheng SH; Huang JL; Chen M; Wang BL; Ou QS; Huang SY J Neurosurg; 2018 Sep; 129(3):583-592. PubMed ID: 29099300 [TBL] [Abstract][Full Text] [Related]
11. Preoperative Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and CEA as the Potential Prognostic Biomarkers for Colorectal Cancer. Ming-Sheng F; Mei-Ling D; Xun-Quan C; Yuan-Xin H; Wei-Jie Z; Qin-Cong P Can J Gastroenterol Hepatol; 2022; 2022():3109165. PubMed ID: 35028301 [TBL] [Abstract][Full Text] [Related]
12. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390 [TBL] [Abstract][Full Text] [Related]
13. [Associations of Preoperative Platelet-to-lymphocyte Ratio and Derived Neutrophil-to-lymphocyte Ratio with thePrognosis of Gastrointestinal Stromal Tumor]. Yin XN; Tang SM; Yin Y; Shen CY; Zhang B; Chen ZX Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 48(2):239-243. PubMed ID: 28612534 [TBL] [Abstract][Full Text] [Related]
14. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio associations with heart and body dose and their effects on patient outcomes in locally advanced non-small cell lung cancer treated with definitive radiotherapy. Xia WY; Zhu XR; Feng W; Liu J; Wang JM; Lv CX; Zhang Q; Yu W; Cai XW; Fu XL Transl Lung Cancer Res; 2020 Oct; 9(5):1996-2007. PubMed ID: 33209619 [TBL] [Abstract][Full Text] [Related]
15. Neutrophil/Lymphocyte Ratio Is an Independent Prognostic Factor in Elderly Patients with High-Grade Gliomas. Gan Y; Zhou X; Niu X; Li J; Wang T; Zhang H; Yang Y; Liu Y; Mao Q World Neurosurg; 2019 Jul; 127():e261-e267. PubMed ID: 30898756 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratio in breast cancer patients. Huszno J; Kolosza Z Oncol Lett; 2019 Dec; 18(6):6275-6283. PubMed ID: 31788105 [TBL] [Abstract][Full Text] [Related]
17. Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patients. Wu G; Yao Y; Bai C; Zeng J; Shi D; Gu X; Shi X; Song Y Thorac Cancer; 2015 May; 6(3):275-87. PubMed ID: 26273373 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Peripheral Inflammatory Markers in Preoperative Mucosal Melanoma: A Multicenter Retrospective Study. Wang Y; Zhang H; Yang Y; Zhang T; Ma X Front Oncol; 2019; 9():995. PubMed ID: 31649874 [No Abstract] [Full Text] [Related]
19. Prognostic value of preoperative neutrophil-lymphocyte ratio is superior to platelet-lymphocyte ratio for survival in patients who underwent complete resection of thymic carcinoma. Yuan ZY; Gao SG; Mu JW; Xue Q; Mao YS; Wang DL; Zhao J; Gao YS; Huang JF; He J J Thorac Dis; 2016 Jul; 8(7):1487-96. PubMed ID: 27499935 [TBL] [Abstract][Full Text] [Related]
20. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab. Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]